SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-216444
Filing Date
2013-05-13
Accepted
2013-05-13 14:53:38
Documents
4
Period of Report
2013-06-05
Effectiveness Date
2013-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d524365ddef14a.htm DEF 14A 266783
2 GRAPHIC g524365g25p43.jpg GRAPHIC 215410
3 GRAPHIC g524365g57t76.jpg GRAPHIC 201967
4 GRAPHIC g524365g91o62.jpg GRAPHIC 12749
  Complete submission text file 0001193125-13-216444.txt   860943
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 13836888
SIC: 2836 Biological Products, (No Diagnostic Substances)